Stay updated with breaking news from Focus Following. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EUR/USD may stage a larger recovery over the coming days as the Relative strength Index (RSI) bounces back from oversold territory to indicate a textbook buy signal.
Aytu BioPharma, Inc.: Aytu BioPharma Divests U.S. Rights to Natesto to Acerus Pharma Strategic Transaction Provides $7.5M in Non-Dilutive Capital and Enables Pediatric and ADHD Product Focus Following the Recently Closed Merger with Neos Therapeutics ENGLEWOOD, CO / ACCESSWIRE / April 1, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU) a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the signing of an agreement with Acerus Pharmaceuticals Corporation (ASP)(ASPCF) whereby Acerus will acquire all remaining rights to Nate...